Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Jun;52(5):435-7.

[Intramuscular ketorolac compared to subcutaneous tramadol in the initial emergency treatment of renal colic]

[Article in Spanish]
Affiliations
  • PMID: 10427881
Clinical Trial

[Intramuscular ketorolac compared to subcutaneous tramadol in the initial emergency treatment of renal colic]

[Article in Spanish]
J A Nicolás Torralba et al. Arch Esp Urol. 1999 Jun.

Abstract

Objective: To compare the efficacy and safety of two analgesics (tramadol and ketorolac) for initial emergency treatment of renal colic.

Methods: A prospective study on 48 patients randomly assigned to treatment with ketorolac 30 mg i.m. and tramadol 1 mg/kg s.c. Pain intensity was evaluated by a simple analogic scale ranging from 0-4 (0 = no pain, 1 = mild, 2 = moderate, 3 = severe and 4 = very severe pain). Statistical analyses were performed with Student's test and the chi square test for numerical and qualitative data, respectively.

Results: No significant differences were found for the overall efficacy (> 80%) or side effects in both groups. However, a difference was found between both groups for pain score 15 minutes post-injection, which showed i.m. ketorolac to be more effective.

Conclusion: Both ketorolac (30 mg i.m.) and tramadol (1 mg/kg s.c.) are effective in the initial treatment of renal colic. Both drugs have an efficacy greater than 80% when used separately and almost 100% when used in combination. The analgesic effect of ketorolac is observed earlier than that of tramadol.

PubMed Disclaimer

LinkOut - more resources